Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $48,946 | 2,606 | 98.5% |
| Education | $700.16 | 27 | 1.4% |
| Gift | $59.43 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,477 | 226 | $0 (2024) |
| ABBVIE INC. | $4,672 | 250 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,536 | 137 | $0 (2024) |
| Novo Nordisk Inc | $3,043 | 143 | $0 (2024) |
| Allergan, Inc. | $2,944 | 274 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,867 | 174 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,070 | 109 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $1,535 | 116 | $0 (2024) |
| Amgen Inc. | $1,529 | 83 | $0 (2024) |
| Astellas Pharma US Inc | $1,467 | 54 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,989 | 219 | ABBVIE INC. ($651.48) |
| 2023 | $4,922 | 255 | ABBVIE INC. ($575.07) |
| 2022 | $5,977 | 303 | ABBVIE INC. ($682.80) |
| 2021 | $7,456 | 397 | AbbVie Inc. ($1,777) |
| 2020 | $4,920 | 295 | Allergan, Inc. ($926.69) |
| 2019 | $5,964 | 356 | AstraZeneca Pharmaceuticals LP ($1,320) |
| 2018 | $7,786 | 400 | AstraZeneca Pharmaceuticals LP ($1,004) |
| 2017 | $7,690 | 412 | Allergan Inc. ($897.05) |
All Payment Transactions
2,637 individual payment records from CMS Open Payments — Page 1 of 106
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $28.23 | General |
| Category: GI | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Analgesic | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Biological | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Biological | ||||||
| 12/03/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $149.50 | General |
| Category: Pain Management | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: PAIN | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.21 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $33.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $75.16 | General |
| Category: Hematology | ||||||
| 11/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/11/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 591 | 1,219 | $119,303 | $56,969 |
| 2022 | 15 | 667 | 1,528 | $134,570 | $66,075 |
| 2021 | 16 | 708 | 1,423 | $122,742 | $67,717 |
| 2020 | 15 | 716 | 1,329 | $109,365 | $59,168 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 290 | $58,000 | $31,749 | 54.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $17,300 | $8,996 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 61 | $12,400 | $5,036 | 40.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $3,250 | $1,966 | 60.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 100 | 336 | $1,680 | $1,646 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 35 | $1,750 | $1,259 | 72.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 35 | 36 | $3,500 | $1,172 | 33.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 13 | $2,600 | $1,008 | 38.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 65 | 90 | $4,500 | $968.76 | 21.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 72 | $3,600 | $939.40 | 26.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 17 | 22 | $1,650 | $761.64 | 46.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 17 | $1,060 | $732.76 | 69.1% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 33 | 86 | $688.00 | $331.10 | 48.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $2,200 | $242.88 | 11.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 33 | $825.00 | $112.53 | 13.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 16 | 45 | $4,300 | $48.11 | 1.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 310 | $60,800 | $34,429 | 56.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 73 | 73 | $21,300 | $11,464 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 110 | $22,150 | $9,052 | 40.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 19 | 26 | $5,200 | $1,989 | 38.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 82 | 118 | $5,900 | $1,363 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 37 | $1,850 | $1,307 | 70.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 25 | 35 | $2,625 | $1,222 | 46.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 110 | 394 | $1,970 | $1,168 | 59.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 18 | $1,350 | $1,102 | 81.6% |
About Dr. Khalil Innabi, M.D
Dr. Khalil Innabi, M.D is a Family Medicine healthcare provider based in Yonkers, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336184290.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalil Innabi, M.D has received a total of $49,705 in payments from pharmaceutical and medical device companies, with $4,989 received in 2024. These payments were reported across 2,637 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($48,946).
As a Medicare-enrolled provider, Innabi has provided services to 2,682 Medicare beneficiaries, totaling 5,499 services with total Medicare billing of $249,929. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Yonkers, NY
- Active Since 06/17/2006
- Last Updated 09/27/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336184290
Products in Payments
- JARDIANCE (Drug) $2,497
- LINZESS (Drug) $2,226
- FARXIGA (Drug) $2,180
- VRAYLAR (Drug) $1,869
- Ozempic (Drug) $1,541
- TRELEGY ELLIPTA (Drug) $1,361
- XIFAXAN (Drug) $1,246
- UBRELVY (Drug) $1,137
- ZTLido (Drug) $1,098
- TRULANCE (Drug) $950.11
- XARELTO (Drug) $927.55
- ENTRESTO (Drug) $850.68
- ELIQUIS (Drug) $790.85
- Vascepa (Drug) $760.46
- BYDUREON (Drug) $745.04
- RELISTOR (Drug) $743.87
- ZENPEP (Drug) $723.70
- Horizant (Drug) $686.47
- Amitiza (Drug) $681.67
- Livalo (Drug) $650.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Yonkers
Dr. Richard Khalil, M.d, M.D
Family Medicine — Payments: $119,883
Luay Marji, Md, MD
Family Medicine — Payments: $51,943
Dr. Martin Sayegh, Md, MD
Family Medicine — Payments: $32,365
Dr. Iyad Annabi, M.d, M.D
Family Medicine — Payments: $30,657
Dr. Ammir Rabadi, M.d, M.D
Family Medicine — Payments: $28,009
Caridad Fresneda, Md, MD
Family Medicine — Payments: $17,888